Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018

J Infect Dis. 2022 Sep 13;226(5):896-900. doi: 10.1093/infdis/jiac011.

Abstract

Hepatitis B virus (HBV) infection causes hepatocellular carcinoma but its association with other cancers is not well established. We compared age-adjusted incidence of primary cancers among 5773 HBV-infected persons with US cancer registries during 2006-2018. Compared with the US population, substantially higher incidence among HBV-infected persons was observed for hepatocellular carcinoma (standardized rate ratio [SRR], 30.79), gastric (SRR, 7.95), neuroendocrine (SRR, 5.88), cholangiocarcinoma (SRR, 4.62), and ovarian (SRR, 3.72) cancers, and non-Hodgkin lymphoma (SRR, 2.52). Clinicians should be aware of a heightened potential for certain nonhepatic malignancies among hepatitis B patients, as earlier diagnosis favors improved survival.

Keywords: cancer; hepatitis B; incidence.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Carcinoma, Hepatocellular* / epidemiology
  • Delivery of Health Care
  • Hepatitis B virus
  • Hepatitis B* / complications
  • Hepatitis B, Chronic* / complications
  • Hepatitis B, Chronic* / epidemiology
  • Humans
  • Incidence
  • Liver Neoplasms* / epidemiology

Grants and funding